Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components | Zendy

NaeYun Heo | Zendy; Seung Ha Park | Zendy; Joon Hyuk Choi | Zendy; Eunju Kim | Zendy; Tae Oh Kim | Zendy; Jongha Park | Zendy; Jin Lee | Zendy; Yong Eun Park | Zendy; Eun Hye Oh | Zendy; Jun Seong Hwang | Zendy; Su Jin Jeong | Zendy

Open Access

Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components

Author(s) -

NaeYun Heo,

Seung Ha Park,

Joon Hyuk Choi,

Eunju Kim,

Tae Oh Kim,

Jongha Park,

Jin Lee,

Yong Eun Park,

Eun Hye Oh,

Jun Seong Hwang,

Su Jin Jeong

Publication year - 2021

Publication title -

korean journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.203

H-Index - 25

eISSN - 2233-6869

pISSN - 1598-9992

DOI - 10.4166/kjg.2020.158

Subject(s) - medicine , ursodeoxycholic acid , gastroenterology , metabolic syndrome , steatosis , transient elastography , placebo , steatohepatitis , chronic liver disease , fatty liver , liver disease , cirrhosis , disease , pathology , liver fibrosis , alternative medicine , obesity

Steatohepatitis related to metabolic syndrome is a chronic liver disease prevalent in patients not only with non-alcoholic steatohepatitis but also with alcoholic liver disease and chronic viral hepatitis. On the other hand, there is limited data on the effects of hepatotonic agents in these patients. Therefore, this study evaluated the efficacy of a combined hepatotonic agent in this population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research